Onward Medical N.V. (EBR:ONWD)
Belgium · Delayed Price · Currency is EUR 2.550
+0.035 (1.39%)
Jul 1, 2026, 5:35 PM CET
Onward Medical Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, Onward Medical stock has a consensus rating of "Strong Buy" and an average price target of €9.24. The average 1-year stock price forecast is 262.35% higher than the current stock price, while the lowest is €8.10 (+217.65%) and the highest is €11.00 (+331.37%).
Price Target: €9.24 (+262.35%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Onward Medical stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 5 |
Financial Forecast
Revenue This Year
12.19M
from 5.41M
Increased by 125.16%
Revenue Next Year
30.57M
from 12.19M
Increased by 150.76%
EPS This Year
-0.84
from -0.90
EPS Next Year
-0.64
from -0.84
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is EUR.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 14.2M | ||
| Avg | 12.2M | ||
| Low | 10.5M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 162.3% | ||
| Avg | 125.2% | ||
| Low | 93.1% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -0.78 | ||
| Avg | -0.84 | ||
| Low | -0.92 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | - | ||
| Low | - |